FDA Compounding is a recurring topic in our peptide coverage. This hub collects every article tagged FDA Compounding, newest first, each evidence-graded and tied to real, verifiable sources.
"Legal" is not one question but five — FDA approval, compounding eligibility, DEA scheduling, WADA sport status, and state telehealth law. A date-stamped 2026 explainer of where peptides actually stand.
A clinical monograph on sermorelin — the GHRH(1-29) growth-hormone secretagogue once FDA-approved for diagnosis and pediatric GH deficiency. Real but modest, mostly pre-2000 human trials; the anti-aging marketing outruns the data.
A clinical monograph on glutathione (GSH) — the body's master antioxidant tripeptide marketed for skin lightening, liver support and 'detox.' Real human RCTs for raising body stores, mixed cosmetic data, and dangerous unapproved IV use.
A clinical monograph on GHRP-2 (pralmorelin) — the ghrelin-receptor agonist approved in Japan as a single-dose GH-deficiency diagnostic. Grade-A acute GH provocation, no chronic-use evidence, and a restrictive 2026 legal status.
A clinical monograph on epitalon (epithalon, AEDG) — the synthetic pineal tetrapeptide marketed as a telomerase-activating geroprotector. Real circadian and cell-culture signals, no Western RCT, and a 2026 FDA inflection point.
FDA Compounding is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.
This hub updates automatically whenever a new article is tagged FDA Compounding, so the latest coverage appears first.
Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.